Change in the presepsin level in hemodialysis patients with pneumonia and sepsis

The research objective is to study presepsin as an inflammation marker to improve diagnosis of severe pneumonia
and sepsis in patients on hemodialysis.
Materials and methods. 42 patients with severe pneumonia, sepsis, chronic glomerulonephritis and nephropathy
aged from 17 to 77 years were examined. Among them, 18 patients received hemodialysis. Presepsin level was
quantified on immunochemiluminiscent analyzer Pathfast (Mitsubishi Chemical Medience Corporation, Japan).